STOCK TITAN
  1. Home
  2. News
  3. YCBD

cbdMD Inc - YCBD STOCK NEWS

Welcome to our dedicated news page for cbdMD (Ticker: YCBD), a resource for investors and traders seeking the latest updates and insights on cbdMD.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect cbdMD's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of cbdMD's position in the market.

News
cbdMD Reduces Year over Year Net Loss from Operations by $3.0 Million
Rhea-AI Summary
cbdMD, Inc. (YCBD) reports financial results for Q1 of fiscal 2024, showing improvements in operating loss, gross profit, and non-GAAP adjusted loss. The company launched new brands, ATRx Labs and HempMD, diversifying into new markets. Net sales decreased by 12%, with DTC net sales down by 10%. Despite a decrease in revenue, the company reduced operating expenses, leading to a lower net loss per share. Notable updates include expansion into Sprouts Markets, Amazon USA, and receiving orders for ATRx Labs products from a national retailer.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.57%
Tags
none
-
News
cbdMD, Inc. to Host Conference Call to Discuss First Quarter of Fiscal 2024 Results
Rhea-AI Summary
cbdMD, Inc. will host a conference call on February 13, 2024, to discuss the company's first quarter financial results and business progress.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.94%
Tags
conferences earnings
-
News
cbdMD Welcomes Vice President of Wholesale Sales, Joe Baghadjian- Paving the Way for Future Growth
Rhea-AI Summary
cbdMD, Inc. (NYSE American: YCBD) appoints Joe Baghadjian as Vice President of Wholesale Sales. Baghadjian's extensive experience in CBD sales and scientific background make him a valuable addition to the company, bringing multilingual skills and international contacts for global expansion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.19%
Tags
none
News
cbdMD Announces Financing of $1,250,000
Rhea-AI Summary
cbdMD, Inc. (YCBD) has entered into a securities purchase agreement with five institutional investors, raising $1,250,000 in gross proceeds. The company issued Senior Secured Original Issue Discount Convertible Promissory Notes to the investors, with an aggregate principal amount of $1,541,666. The Notes mature in 18 months and are convertible into common stock at an initial conversion price of $0.684 per share. The company plans to use the proceeds for working capital and to fund the national rollout of its ATRx Labs functional mushroom products, which have been nominated for seven awards at the 2024 WholeFoods Magazine Natural Choice Awards. Additionally, the company aims to strengthen its revenue-focused staff and utilize the remaining proceeds for general working capital and administrative purposes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
cbdMD Unveils THCV+CBG Energy Softgels, Ushering in a New Era of Wellness Solutions
Rhea-AI Summary
cbdMD, Inc. unveils THCV+CBG Energy Softgels, a unique product integrating THCV and CBG cannabinoids with caffeine and B12 to enhance energy, focus, and clarity. Priced at $64.99, the softgels are available for purchase on cbdMD's website, reflecting the company's commitment to innovation and quality in the CBD market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.9%
Tags
none
-
News
cbdMD Launches into Sprouts Farmers Market, Bringing Premium CBD Gummies to 175 Stores Nationwide
Rhea-AI Summary
cbdMD, Inc. (NYSE American: YCBD) has launched its premium cannabidiol (CBD) products, Apple Cider Vinegar (ACV) and Immunity Gummy Pouches, in 175 Sprouts Farmers Market locations nationwide. The partnership with Sprouts Farmers Market solidifies cbdMD's reputation for quality products and aligns with Sprouts' commitment to natural options. The products are vegan-friendly, gluten-free, and Farm Bill Compliant, catering to a broad spectrum of dietary needs and preferences.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.32%
Tags
none
News
cbdMD Reduces Year over Year Net Loss from Operations by $55.8 Million
Rhea-AI Summary
cbdMD, Inc. (NYSE American: YCBD) announced the launch of HempMD products and nutraceutical brand ATRx, along with a new functional mushroom product to expand growth opportunities and markets. The company reported a loss from operations of $22.4 million for Fiscal 2023, including one-time intangible impairment charges of $13.2 million. Excluding these charges, significant year-over-year improvements to operating loss were made. The company has made progress on its path to positive cash flow, exhibited operational excellence, and expanded into 160 Sprouts Markets stores across the nation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
cbdMD, Inc. to Host Conference Call to Discuss September 30, 2023 Fourth Quarter and Fiscal Year 2023 Results
Rhea-AI Summary
cbdMD, Inc. (NYSE American: YCBD) to Host Conference Call to Discuss Q4 and Full Year Fiscal 2023 Financial Results and Business Progress
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.01%
Tags
conferences earnings
-
News
cbdMD Wins Awards in Two Categories at Prestigious Best in Biz Awards
Rhea-AI Summary
cbdMD (NYSE American: YCBD) wins two bronze awards at the Best in Biz Awards for their CBD Freeze Roll-On and CBD PM Softgel Capsules - NSF Certified for Sport. The Freeze Roll-On provides quick relief from temporary muscle and joint discomfort, while the Softgel Capsules are the first CBD product to earn the NSF Certified for Sport certification.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.63%
Tags
none
News
cbdMD Announces Cancellation of Special Meeting
Rhea-AI Summary
cbdMD cancels vote on automatic conversion of Series A Preferred Stock due to insufficient proxies. Management to focus on business and explore strategic alternatives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.04%
Tags
none
Stock YCBD logo
cbdMD Inc

NYSE:YCBD

YCBD Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

YCBD Stock Data

2.79M
2.50M
21.19%
8.06%
12.13%
Other Services Related to Advertising
Professional, Scientific, and Technical Services
Link
United States
Charlotte

About YCBD

cbdmd, inc. produces and distributes various cannabidiol (cbd) products. it owns and operates consumer hemp-based cbd brands, such as cbdmd and paw cbd. its cbdmd brand products include cdb tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. the company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the paw cbd brand name. it distributes its products through its e-commerce website, third party e-commerce sites, wholesalers, and various brick and mortar retailers in the united states. the company was formerly known as level brands, inc. and changed its name to cbdmd, inc. in may 2019. cbdmd, inc. was founded in 2015 and is headquartered in charlotte, north carolina.